Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart

British Journal of Pharmacology

Volumn 144, Issue 6, 2005, Pages 860-866

  Gonon, Adrian T ^a   Bulhak, Alexander ^a   Bröijersén, Anders ^a   Pernow, John ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Endothelin 1; Ischaemia; Nitric oxide; Reperfusion

Indexed keywords

APOLIPOPROTEIN E; BOSENTAN; DRUG VEHICLE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; LOW DENSITY LIPOPROTEIN RECEPTOR; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HISTOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; WILD TYPE;

ANIMALS; ARTERIOSCLEROSIS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; FIBROSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE; RECEPTORS, ENDOTHELIN; REPERFUSION; SULFONAMIDES;

EID: 17144362545     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706117     Document Type: Article

References (29)

1. BARTON, M., HAUDENSCHILD, C.C., D'USCIO, L.V., SHAW, S., MUNTER, K. & LÜSCHER, T.F. (1998). Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A., 95, 14367-14372.
2. BOHM, F., AHLBORG, G., JOHANSSON, B.L., HANSSON, L.O. & PERNOW, J. (2002a). Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 22, 674-679.
3. BOHM, F., AHLBORG, G. & PERNOW, J. (2002b). Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin. Sci. (London), 102, 321-327.
4. BOULANGER, C. & LÜSCHER, T.F. (1990). Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest., 85, 587-590.
5. BRUNNER, F., LEONHARD, B., KUKOVETZ, W.R. & MAYER, B. (1997). Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart. Cardiovasc. Res., 36, 60-66.
6. CALIGIURI, G., LEVY, B., PERNOW, J., THOREN, P. & HANSSON, G.K. (1999). Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U.S.A., 96, 6920-6924.
7. CLOZEL, M., BREU, V., GRAY, O.A., KALINA, B., LOFFLER, B.M., BURRI, K., CASSAL, J.M., HIRTH, G., MULLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
8. DETMERS, P.A., HERNANDEZ, M., MUDGETT, J., MASSING, H., BURTON, C., MUNDT, S., CHUN, S., FLETCHER, D., CARD, D.J., LISNOCK, J., WEIKEL, R., BERGSTROM, J.D., SHEVELL, D.E., HERMANOWSKI-VOSATKA, A., SPARROW, C.P., CHAO, Y.S., RADER, D.J., WRIGHT, S.D. & PURE, E. (2000). Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol., 165, 3430-3435.
9. D'USCIO, L.V., BARTON, M., SHAW, S. & LÜSCHER, T.F. (2002). Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. Cardiovasc. Res., 53, 487-495.
10. GONON, A.T., ERBAS, D., BROIJERSEN, A., VALEN, G. & PERNOW, J. (2004). Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol., 286, H1767-H1774.
11. GONON, A.T., GOURINE, A.V. & PERNOW, J. (2000). Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production. J. Cardiovasc. Pharmacol., 36, 405-412.
12. GONON, A.T., WANG, Q.D. & PERNOW, J. (1998). The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion. Cardiovasc. Res., 39, 674-682.
13. GOURINE, A.V., GONON, A.T. & PERNOW, J. (2001). Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol., 280, H1105-H1112.
14. HASDAI, D., MATHEW, V., SCHWARTZ, R.S., SMITH, L.A., HOLMES JR, D.R., KATUSIC, Z.S. & LERMAN, A. (1997). Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol., 17, 2737-2743.
15. JIANG, J., VALEN, G., TOKUNO, S., THOREN, P. & PERNOW, J. (2000). Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br. J. Pharmacol., 131, 1255-1261.
16. KOBAYASHI, T., MIYAUCHI, T., IWASA, S., SAKAI, S., FAN, J., NAGATA, M., GOTO, K. & WATANABE, T. (2000). Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis. Pathol. Int., 50, 929-936.
17. KOUREMBANAS, S., MARSDEN, P.A., MCQUILLAN, L.P. & FALLER, D.V. (1991). Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest., 88, 1054-1057.
18. LIBBY, P. (2000). Changing concepts of atherogenesis. J. Intern. Med., 247, 349-358.
19. LÜSCHER, T.F. & NOLL, G. (1995). The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis, 118 (Suppl), S81-S90.
20. NAKASHIMA, Y., PLUMP, A.S., RAINES, E.W., BRESLOW, J.L. & ROSS, R. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb., 14, 133-140.
21. PLUMP, A.S., SMITH, J.D., HAYEK, T., AALTO-SETALA, K., WALSH, A., VERSTUYFT, J.G., RUBIN, E.M. & BRESLOW, J.L. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell, 71, 343-353.
22. ROSS, R. (1999). Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 340, 115-126.
23. SCALIA, R., GOOSZEN, M.E., JONES, S.P., HOFFMEYER, M., RIMMER III, D.M., TROCHA, S.D., HUANG, P.L., SMITH, M.B., LEFER, A.M. & LEFER, D.J. (2001). Simvastatin exerts both antiinflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation, 103, 2598-2603.
24. TOKUNO, S., HINOKIYAMA, K., TOKUNO, K., LOWBEER, C., HANSSON, L.O. & VALEN, G. (2002). Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia. Arterioscler. Thromb. Vasc. Biol., 22, 995-1001.
25. WANG, Q.D., HEMSEN, A., LI, X.S., LUNDBERG, J.M., URIUDA, Y. & PERNOW, J. (1995a). Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc. Res., 29, 44-49.
26. WANG, Q.D., LI, X.S. & PERNOW, J. (1995b). The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart. J. Cardiovasc. Pharmacol., 26 (Suppl 3), S445-S447.
27. WANG, Q.D., URIUDA, Y., PERNOW, J., HEMSEN, A., SJOQUIST, P.O. & RYDEN, L. (1995c). Myocardial release of endothelin (ET) and enhanced ET(A) receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs. J. Cardiovasc. Pharmacol., 26, 770-776.
28. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
29. ZHANG, S.H., REDDICK, R.L., PIEDRAHITA, J.A. & MAEDA, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 258, 468-471.